Key Insights

Highlights

Success Rate

76% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

11.4%

9 terminated out of 79 trials

Success Rate

76.3%

-10.2% vs benchmark

Late-Stage Pipeline

10%

8 trials in Phase 3/4

Results Transparency

7%

2 of 29 completed with results

Key Signals

2 with results76% success

Data Visualizations

Phase Distribution

50Total
Not Applicable (34)
Early P 1 (1)
P 1 (2)
P 2 (5)
P 3 (1)
P 4 (7)

Trial Status

Completed29
Unknown16
Recruiting12
Terminated9
Withdrawn5
Enrolling By Invitation5

Trial Success Rate

76.3%

Benchmark: 86.5%

Based on 29 completed trials

Clinical Trials (79)

Showing 20 of 20 trials
NCT07506746Recruiting

PRospective Registry of Esophageal Motility

NCT07496840Recruiting

Clinical Outcomes, Safety, and Effectiveness of Speedboat UltraSlim™ in Per-Oral Endoscopic Myotomy (POEM)

NCT06738628Not Yet RecruitingPrimary

Disposable Endoscope Platform in Third Space Endoscopic Procedures

NCT01793922Not ApplicableCompletedPrimary

POEM Trial: Multi-center Study Comparing Endoscopic Pneumodilation and Per Oral Endoscopic Myotomy (POEM)

NCT02770859Enrolling By InvitationPrimary

Per-Oral Endoscopic Myotomy (POEM) for the Treatment of Achalasia, Database Repository

NCT07406945Not ApplicableRecruitingPrimary

Safety and Efficacy of a Novel SpydrBlade Flexible Bipolar in POEM

NCT05905016RecruitingPrimary

Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders

NCT01799967Active Not RecruitingPrimary

Minimally Invasive Surgery of the Gastro-esophageal Junction

NCT03123835Not ApplicableEnrolling By InvitationPrimary

Outcome Analysis of POEM and Endoluminal Therapies

NCT04641702Phase 4RecruitingPrimary

Comprehensive Esophageal Diagnostics Study

NCT01512719Not ApplicableCompletedPrimary

POEM- Peroral Endoscopic Myotomy for Esophageal Motility Disorders

NCT07181070Recruiting

The Use of Indocyanine Green Fluorescence (ICG) During Laparoscopic Heller- Dor

NCT03654066Phase 4Enrolling By InvitationPrimary

Botox or Botox With Esophageal Dilation in Patients With Achalasia

NCT05550194Phase 4RecruitingPrimary

VZV in the Enteric Nervous System: Pathogenesis and Consequences

NCT03063463Enrolling By InvitationPrimary

Mechanisms of Weight Loss in Patients Diagnosed With Achalasia

NCT06189859Phase 3RecruitingPrimary

Electrosurgical Modes for Endoscopic Submucosal Dissection in Peroral Endoscopic Esophageal Myotomy

NCT04065516Not ApplicableEnrolling By InvitationPrimary

ARAT for Reflux Disease After Peroral Endoscopic Myotomy in Patients With Achalasia

NCT02482337Not ApplicableTerminatedPrimary

Per-Oral Endoscopic Myotomy for Esophageal Swallowing Disorders

NCT06042127Not ApplicableRecruitingPrimary

POEM-F for Achalasia International Study

NCT01832779CompletedPrimary

Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia

Scroll to load more

Research Network

Activity Timeline